期刊文献+

圣脑康丸的抗炎镇痛作用 被引量:2

Study on Shengnaokang pill of anti-inflammatory and analgesic
原文传递
导出
摘要 目的:对治疗心脑血管疾病成药圣脑康丸的抗炎镇痛作用进行研究,探讨中药在治疗心脑血管疾病中的抗炎镇痛作用。方法:以阿司匹林为阳性药,采用角叉菜胶致大鼠足跖肿胀和二甲苯致小鼠耳肿胀的模型,研究圣脑康丸的抗炎作用;用热板法、醋酸扭体和光电甩尾实验研究该制剂的镇痛作用。结果:1.0~4.0g/Kg的剂量给药圣脑康丸对角叉菜胶致大鼠足跖肿胀有抑制作用;以3.0~6.0g/Kg的剂量给药圣脑康丸能显著抑制二甲苯致小鼠耳肿胀;以3.0~6.0g/Kg的剂量给药圣脑康丸能提高热板法引起小鼠的痛阀值,延长小鼠光电甩尾的潜伏期以及减少醋酸致小鼠的扭体次数。结论:作为治疗心脑血管疾病的复方制剂圣脑康丸在该实验中显示出良好的抗炎镇痛作用。 Objective:To study the anti-inflammatory and analgesic effect of the treatment of cardiovascular and cerebrovascular diseases drugs of Shengnaokang Pill and explore the role played by the anti-inflammatory analgesic in the treatment of cardiovascular and cerebrovascular diseases.Methods:Aspirin is positive drug,carrageenin-induced rat paw edema model and dimethylbenzene(DB)-induced mouse ear swelling model respectively were used to study anti-inflammatory effect of Shengnaokang Pill.Hot plate,photoelectricity-induced swinging tails and acetic acid writhing method were used to study analgesic effect of Shengnaokang Pill.Results:In comparison with the model controls,at 1.0~4.0 g/Kg doses of Shengnaokang Pill could inhibit to rat paw edema induced by carrageenin.and at 3.0~6.0 g/Kg doses of Shengnaokang showed significant inhibition to DB-induced mouse ear swelling weight.Moreover at 3.0~6.0 g/Kg doses of Shengnaokang could elevate the mouse pain threshold in the mice stimulated by hot plate and photoelectricity,reduced the number of acid-induced writhing.Conclusion:In this experiment,the treatment of cardiovascular and cerebrovascular diseases compound drug of shengnaokang pill has showed significant anti-inflammatory and analgesic effect.
出处 《中药药理与临床》 CAS CSCD 北大核心 2012年第5期180-183,共4页 Pharmacology and Clinics of Chinese Materia Medica
关键词 心脑血管疾病 圣脑康丸 抗炎 镇痛 Shengnaokang Pill(圣脑康丸) anti-inflammatory analgesic
  • 相关文献

参考文献6

二级参考文献48

  • 1宋红儒,汤迎爽,杨丽甲.HPLC法测定圣脑康丸中阿魏酸的含量[J].解放军药学学报,2004,20(5):375-376. 被引量:9
  • 2王毅,牛文忠,李明,李江.藏成药对进藏新兵运动后血氧饱和度的影响[J].西南国防医药,2005,15(5):485-487. 被引量:4
  • 3宋红儒 汤迎爽 杨丽甲 等.圣脑康丸的质量标准研究.中华现代临床医学,2006,4(23):2133-1234.
  • 4Kelm M,Rath J.Endothelial dysfunction in human coronary circulation:relevance of the L-arginine-NO pathway [J].Basic Res Cardiol,2001,96:107-127.
  • 5Burke AP,Tracy RP,Kolodgie F,et al.Elevated C-reactive protein values and atherosclerosis in sudden coronary death:association with different pathologies [J].Circulation,2002,105:2019-2023.
  • 6Ridker PM.Clinical application of C-reactive protein for cardiovascular disease detection and prevention [J].Circulation,2003,107:363-369.
  • 7Ridker PM,Buring JE,Cook NR,et al.C-reactive protein,the metabolic syndrome,and risk of incident cardiovascular events.An 8-year follow-up of 14 719 initially healthy American women [J].Circulation,2003,107:391-397.
  • 8Stefanadis C,Diamantopoulos L,Vlachopoulos C,et al.Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo.A new method of detection by application of a special thermography catheter [J].Circulation,1999,99:1965-1971.
  • 9Naghavi M,John R,Naguib S,et al.pH heterogeneity of human and rabbit atherosclerotic plaques:a new insight into detection of vulnerable plaque [J].Atherosclerosis,2002,164:27-35.
  • 10Bertram P,Carl P,James TW.Cyclooxygenase-2 inhibition and cardiovascular events [J].Circulation,2002,106:167-169.

共引文献12

同被引文献24

  • 1王忠壮,苏中武,李承祜,郑汉臣,檀密艳,王中胜.中药九眼独活的商品调查及生药鉴定[J].中国中药杂志,1994,19(12):707-709. 被引量:11
  • 2彭腾,董小萍,邓赟,涂永勤,李小年.栽培食用土当归根的化学成分研究[J].中药材,2005,28(11):996-998. 被引量:11
  • 3宁晚英.六味地黄丸和复方丹参片治疗轻中度高血压22例疗效观察[J].湖南中医杂志,1997,13(4):8-8. 被引量:15
  • 4CHEN L,ZHAO Y,ZHANG l,et al.Protective effect of Sheng-Nao-Kang decoction on focal cerebral ischemia-reperfusion injury in rats[J].Journal of Ethnopharmacology,2014,151(1):228-236.
  • 5DANG X,MIAO J J,CHENG A Q,et al.The antithrombotic effect of RSNK in blood-stasis model rats[J].Original Research Article Journal of Ethnopharmacology,2015,173(15):266-272.
  • 6GOODE G K,MILLER J P,HEAGERTY A M.Hyperlipidemia,hyperten-sion,and coronary heart disease[J].Lancet,1995,345(8946):362-364.
  • 7YOUNG D B,LIN H,MCCABE R D.Potassium's cardiovascular protective mechanisms[J].Am J Physiol,1995,268(4Pt2):R825-837.
  • 8BLANTON R M,TAKIMOTO E,ARONOVITZ M,et al.Mutation of the protein kinase I alpha leucine zipper domain produces hypertension and progressive left ventricular hypertrophy:a novel mouse model of agedependent hypertensive heart disease[J].The Journals of Gerontology Series A:Biological Sciences and Medical Sciences,2013,68(11):1351-1355.
  • 9CHAHAL N S,LIM T K,JAIN P,et al.The increased prevalence of left ventricular hypertrophy and concentric remodeling in UK Indian Asians compared with European Whites[J].Journal of Human Hypertension,2013,27(5):288-293.
  • 10TSIACHRIS D,TSIOUFIS C,KASIAKOGIAS A,et al.Persistent resistant hypertension during long term follow-up is related with lack of regression of left ventricular hypertrophy in essential hypertensives[J].European Heart Journal,2013,34(suppl 1):568-569.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部